Nkarta, Inc. logo

NKTXNkarta, Inc.

NKTX Stock Price, Valuation & Chart | Nkarta, Inc.

Compare

NKTX Historical price chart

NKTX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization197.82M
PE Ratio-1.76
EPS-1.57
Trading Volume489.60K
Today's High/Low2.83/2.65
Dividend Yield0.00
52 Week High/Low3.72/1.7
Shares Outstanding71.55M
NKTX Financial Statement
NKTX Analyst ratings
NKTX Analysis & performance metrics

NKTX Company profile

Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy…

NKTX Management team

Management
Nadir Mahmood Ph.D.
President and Principal Accounting & Financial Officer
Greg Mann
Vice President of Public Affairs and Investor Relations
Paul J. HastingsCEO
Chief Executive Officer & Director
Total 3 executives

NKTX Frequently asked questions

What is Nkarta, Inc. (NKTX) Stock Price?

Current stock price of Nkarta, Inc. (NKTX) stock is $2.770. The stock price is +2.41% higher in the session. The intraday range can be seen from this page. Volume of Nkarta, Inc. (NKTX) stock is 489.60K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Nkarta, Inc. (NKTX) stock price going up or down today?

The stock price of Nkarta, Inc. (NKTX) can change with earnings, company news, and overall market sentiment. Nkarta, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Nkarta, Inc. stock expensive at its current price?

Whether Nkarta, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NKTX on this page is -1.76. EPS on this page is -1.57. Compare those figures with peers and growth expectations before deciding if the current Nkarta, Inc. price is justified.

How has the stock price of Nkarta, Inc. (NKTX) performed historically?

Historical performance for Nkarta, Inc. (NKTX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NKTX reacted to past earnings and market events.

Should I buy Nkarta, Inc. (NKTX) stock, at this price?

Buying Nkarta, Inc. (NKTX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.